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A B S T R A C T
Aim: It is well known that general anesthetics suppress/alter electrocorticography (ECoG) activity.
However there are no randomized studies available, comparing various anesthetic techniques as regards
their effects on ECoG.
Methods: The following is a double blind, randomized cross over study to compare the effects of
isoﬂurane and propofol with or without nitrous oxide on electrocorticographic activity in patients
undergoing epilepsy surgery.
40 patients suffering from medically intractable epilepsy scheduled to undergo resective surgery
under ECoG guidance under general anesthesia, (March 2008–December 2010) were enrolled. Patients
received either isoﬂurane or propofol (with air/oxygen or nitrous oxide/oxygen) as maintenance agents
as per randomization and ECoG was recorded and quantiﬁed as per a scoring system (range 1–5, where 5
is most abnormal).
Results: The mean ECoG score in isoﬂurane group and propofol with nitrous oxide was 3.0(1.2), 3.2(1.2)
[p = 0.7] and with air was 3.9(1.0) and 3.4(1.1) [p = 0.1] respectively. In both isoﬂurane group and
propofol group addition of nitrous oxide depressed the ECoG score (p  0.01, 0.5 respectively). The total
duration of anesthesia, surgery, emergence time, extubation time, and hospital stay was comparable in
two groups.
Conclusion: In our study optimal ECoG recordings were possible with use of either isoﬂurane or propofol.
Addition of nitrous oxide to either of the anesthetic regimens suppressed the ECoG score.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
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jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
The goals of epilepsy surgery are to identify the epileptogenic
zone from which seizures originate and excise it completely
without complications. Electrocorticography (ECoG) was ﬁrst
described by Penﬁeld and Jasper, to map focal inter-ictal spiking
and mark areas to be resected.1,2 Although, over the years, many
advantages and limitations of ECoG have been described, it is still
used in many centers across the globe.3,4 Intraoperatively, it is very
important for neurosurgeon and neurologist to have optimal
waveforms of ECoG, as decisions based on interpretations of this
guide the surgeon to perform the resection. It is well known that
general anesthetics suppress/alter ECoG activity. Anesthetic agent
may interact with the background activity as well as epileptiform* Corresponding author. Tel.: +91 9868398205; fax: +91 26588663.
E-mail address: prabhakarhemanshu@rediffmail.com (H. Prabhakar).
1059-1311/$ – see front matter  2012 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2012.05.002discharges.4 Thus, role of the anesthesiologist becomes important
in designing the anesthetic technique in such a way that optimal
waveforms of ECoG may be recorded. General anesthetic
techniques for epilepsy surgery remain largely empirical, typically
institution speciﬁc and sparsely described in literature.5,6 There are
no randomized studies available, comparing various anesthetic
techniques to demonstrate their effects on ECoG. Thus this study
was conducted to design an optimal combination of anesthetic
drugs for recording ECoG. The aim of the study was to compare the
effects of isoﬂurane and propofol with or without nitrous oxide on
electrocorticographic activity in patients undergoing epilepsy
surgery in terms of satisfactory identiﬁcation of epileptiform
activity.
2. Materials and methods
Institutional ethics committee approval and informed consent
from all the patients were obtained before commencement of thevier Ltd. All rights reserved.
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consecutive patients suffering from medically intractable epilepsy
evaluated by single neurologist (MT) scheduled to undergo
surgical resection of epileptogenic foci with the use of ECoG
guidance under general anesthesia by single neurosurgeon (PSC)
between March 2008 and December 2010 were enrolled. All
included patients had well deﬁned lesion on MRI (hippocampal
sclerosis, either focal cortical dysplasia, tumor or gliosis) with
deﬁned concordance on inter ictal EEG (electroencephalography),
Video EEG, SPECT (single photon emission tomography) and PET
(positron emission tomography). Cases of hippocampal sclerosis
have also been included as it does come under the deﬁnition of a
‘lesion’ and recordings could easily be performed using a strip
electrode placed over it longitudinally. The size of the grid chosen
was always larger than the size of the lesion. Exclusion criteria
were patients with doubtful concordance or with a more diffuse
surgical substrate, patients with morbid obesity, pregnancy and
known allergy to the anesthetic drugs used. Pre-anesthetic
evaluation included relevant clinical history, complete general
and neurological examination. All the cases were discussed for
possible role of surgery in the epilepsy surgery case conference andTable 1
Clinical data of all patients included in the study.
S. no. Age Sex Weight
(kg)
Diagnosis AED 
Isoﬂurane group
1 15 y M 47 L MTS C,Cl,P,Pb,V 
2 6 y M 20 L insular glioma Cl,Le,V 
3 18 y M 60 Encephalomalacia Le,V 
4 12 y M 38 Cortical dysplasia P,V 
5 12 y M 50 RE P,Oc,La 
6 33 y M 56 L MTS C,Le,V 
7 15 y M 50 L Temporal DNET Cl,Oc,V 
8 19 y M 50 R Temporal SOL Le 
9 12 y M 48 L Frontal gliosis C,V 
10 9 y M 23 R Subpial gliosis C,G,Le 
11 9 m F 7 R Hemimegancephaly Cl,Le,Pb,V 
12 9 y M 24 Encephalomalacia Cl,Le,Oc,V 
13 20 y F 40 T ganglioglioma C,Cl,Le,P,V 
14 4 y M 17 Tuberous sclerosis La,Le,P 
15 25 y F 56 L MTS Le,V 
16 18 y M 56 CB ganglioglioma Cl,P 
17 10 y M 40 L MTS C,Cl,Le,V 
18 17 y F 52 TP foci Cl,Le,Z 
19 9 y F 35 RE Cl,Iv,Le,V 
Propofol group
1 20 y F 40 R MTS C,Cl,La 
2 26 y M 55 R MTS C,Le,Pb 
3 16 y M 49 PO focus C,P,V, 
4 28 y F 67 R Parietal gliosis Cl,Le,V 
5 6 y M 16 L PCA infarct Cl,V 
6 8 y M 25 B/L MTS C,Cl,Le,V 
7 24 y M 60 L T gliosis La,V 
8 16 y F 44 R Porencephalic cyst C,Cl,Le 
9 6 y F 17 Cortical dys Le,Pb,Pg 
10 22 y M 60 R F gliosis P,Pb,V 
11 12 y M 64 R MTS Cl,Le,Oc,V 
12 25 y F 49 R MTS C,Le 
13 2 y M 9 L MTS Cl,Le,Tp,V 
14 10 y M 33 F DNET C,V 
15 18 y M 67 Parietal gliosis La,P,Pb,V 
16 9 y M 32 R T DNET Le,V 
17 28 y M 80 R MTS Cl,P,V 
18 24 y M 85 B/L MTS Le,P,V 
19 24 y M 85 R MTS Cl,P,V 
20 14 y M 55 TP Gliosis Le,P,V 
y: year, m: month, M: male, F: female, L: left, R: right, B/L: bilateral, F: frontal, O: occipit
tumor, RE: Rasmussen’s encephalitis, AED: antiepileptic drugs, C: carbamezipine, Cl: cl
phenytoin, Pb: phenobarbitone, Pg: pregabalin, Tp: topriamate, V: valproate, Z: zonisami
corpus callosotomy, HS: hemispherotomy, ECoG: electrocorticography, N/V: nausea vom
ICH: intracranial hematoma, PN: pneumocephalus, Hyper Na: hypernatremia, Hypo Na: 
lost: patients lost to follow up.underwent standard workup for medically intractable epilepsy
including inter-ictal EEG, VEEG, MRI (magnetic resonance imag-
ing), SPECT, PET, subtraction ictal SPECT co-registered to MRI.
Preoperatively, all patients were kept fasting according to the
standard guidelines and received antisialogogue premedication
(40 m/kg intramuscular glycopyrrolate in adults or 20 m/kg oral
atropine in pediatric patients) before being shifted to the operation
theater. Patients continued to take all antiepileptic drugs till the
morning of surgery (Table 1). No sedative premedication was
given. Inside the operation theater, monitoring with 5-lead
electrocardiography (ECG), non-invasive blood pressure (NIBP),
pulse oximetry and bispectral index (BIS) (Aspect Medical System,
A-2000, USA) was performed. BIS is a numerical index ranges from
100 (awake) to 0 (isoelectric EEG). BIS values of 40–60 reﬂect
adequate hypnotic effect for general anesthesia with reasonably
rapid recovery to consciousness. In adults and co-operative
patients, general anesthesia was induced with fentanyl 2 mg/kg
and thiopentone 3–5 mg/kg, whereas in small children and un-
cooperative patients inhalational induction was done using
sevoﬂurane in oxygen. Tracheal intubation was facilitated by
rocuronium 1 mg/kg and all patients were mechanically ventilatedProcedure ECoG
(N2O)
ECoG
(air)
Postoperative
complications
Outcome
AMTR 2 3 N/V I
Excision 1 3 – I
Excision 3 4 NEURO DEF, HypoNa II
Excision 3 5 – II
HS 4 5 VN, PN, ICH I
AMTR + Amy 3 5 SZ, Hyponat, NEURO DEF III
Excision 4 5 Shivering I
Excision 5 5 – I
Excision 2 3 VN, hypoNa, NEURO DEF III
F lobectomy 1 4 VN, Fever III
HS 5 4 VN, Fever I
HS 5 4 VN, Fever I
Excision 2 3 – I
F lobectomy 3 2 SZ III
AMTR + Amy 2 3 Fever I
Excision 3 4 – Lost
AMTR 2 4 – Lost
Subdural grid 4 5 SZ, Fever III
HS 4 3 SZ, Fever, ICH I
AMTR 3 2 – Lost
AMTR 5 3 – Lost
Resection 2 4 NEURO DEF II
Resection 4 5 – Lost
C C 4 2 – II
R AMTR 3 2 – II
Resection 3 4 –
HS 4 3 VN, SZ IV
Resection 5 3 Hyper Na I
Resection 4 3 – III
AMTR 2 3 – II
AMTR 2 5 NEURO DEF I
AMTR 2 4 SZ IV
Excision 2 4 – I
Subdural grid 1 3 – Lost
Excision 4 5 – I
R AMTR 2 4 – II
R AMTR 3 4 – III
R AMTR 3 1 Fever I
Resection 5 4 NEURO DEF V
al, P: parietal, T: temporal, CB: cerebellar, DNET: dys-embryoplastic neuroepithelial
obazam, G: gabapantin, La: lamotrigine, Le: leveracitam, Oc: oxycarbamezipine, P:
de, AMTR: anteromedial temporal resection, amy: amygdalahippocampectomy, CC:
iting, VN: postoperative ventilation, NEURO DEF: neurological deﬁcit, SZ: seizure,
hyponatremia, Outcome at 3 months: post operative seizure control at 3 months,24
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was maintained with either isoﬂurane (Group ‘Isoﬂurane’) or propofol
infusion (Group ‘Propofol’) as per a computer generated randomiza-
tion charts. In both the groups the study was divided in two stages
(Fig. 1). In the ﬁrst stage either air or nitrous oxide (N2O) was used in
the inhalation gas mixture (FiO2 0.5) according to randomization. All
patients received infusion of fentanyl 1 mg/kg/h and rocuronium
0.5 mg/kg/h for intra-operative analgesia and muscle relaxation
respectively. Anesthetic depth was maintained by keeping BIS in
range of 50  5 (normal range 40–60). All patients received normal
saline or ringers lactate as intraoperative ﬂuid. Normothermia
(nasopharyngeal temperature 36–37 8C) was maintained using a
forced air warming blanket. A wide craniotomy was performed and
after dural reﬂection a large ECoG grid was placed over the surface of
the brain. Once satisfactory ECoG was obtained with carrier gas under
study (at least for 20 min duration), the ﬁrst gas was turned off and
second gas (either N2O or air) was started marking the second stage of
the study (for another 20 min). In order to eliminate the carry over
effect of the gas under study a washout period of 20 min was allowed
or till the expired gas concentration turned to zero for the gas under
study, before starting the second carrier gas. ECoG was analyzed and
graded by a blinded neurologist using the grading system described
by Marthen et al.7 This scoring was developed for cortical dysplasia,
however this is the only objective scoring available so we used it to
deﬁne objectively the ECoG ﬁndings irrespective of the underlying
pathology.
The ECoG scoring system is brieﬂy described below:
ECoG Score 0: Normal activity.
ECoG Score 1: Normal background of mixed gamma, beta and
alpha frequencies of moderate to low amplitude (i.e.,
usually < 20–30 mV). A few low-amplitude spikes could be
observed.
ECoG Score 2: Loss of fast (>20 Hz) background frequencies, but
otherwise a background of mixed alpha, beta and delta
frequencies of low to moderate amplitude. Repeated but
non-continuous, spikes, polyspikes or paroxysmal fast activity
of medium amplitude often observed.
ECoG Score 3: Mostly 6–20 Hz background frequencies with
some localized nearly continuous interictal epileptiform
features of moderate amplitude or persistent repetitive spiking.
Very rarely, electrographic seizures can be captured.
ECoG Score 4: Slow (<6 Hz) background frequencies with
continuous synchronous features of moderate to high ampli-
tude. Multiple independent epileptiform abnormalities (poly-
spikes, paroxysmal fast activity and electrographic seizures)
could be recorded.
ECoG Score 5: Slow rhythmic usually synchronous background
(<4 Hz), often of high amplitude. Continuous synchronized or
independent high-amplitude epileptiform abnormalities in
multiple cortical sites could be observed. Ictal discharges are
rarely recorded but observed in surrounding cortex.
As per this reference of ECoG scoring, score zero would mean no
spikes, or sharps, high amplitude discharges, etc. Only a
background rhythm ranging from beta to delta low amplitude –
high grades (4 or 5) are deﬁned as multifocal discharges within the
grid domain and not the whole brain. An ECoG score of 2–5 was
considered abnormal.
ECoG recordings were performed using 64 channel machine
(Nicolet, Viasys, USA). The reference electrode was placed over the
forehead and the recordings were performed by both reference and
bipolar derivations. Recordings from neocortical structures were
performed using a large grid (32 contacts) to cover the entire area
representing the lesion and the perilesional area. The recording
from the hippocampus (in mesial temporal sclerosis) was doneafter performing anterolateral temporal lobectomy, followed by
placement of strip (1  4) over the mesial temporal lobe and
hippocampus and ECoG guided amygdalohippocampectomy.8
Anterolateral temporal lobectomy is the standard procedure
performed by our surgeon (PSC) and not selective amygdalohip-
pocampectomy as most of the cases we see have long standing
epilepsy (average 8–9 years) by which time we frequently notice
reactive changes (e.g. signal changes, gliosis atrophy, etc.) within
the parahippocampus and even the lateral temporal structures.
Low frequency ﬁlter was set at 1 Hz and high frequency ﬁlter
was set at 70 Hz and sensitivity was set between 300 and 5000 mV/
mm depending upon the amplitude of background and discharges.
Heart rate (HR), mean arterial pressure (MAP), oxygen
saturation (SPO2), end-tidal carbon dioxide (ETCO2), inspired
fraction of volatile anesthetic agent (FiAA) were constantly
measured. HR and MAP were maintained within 20% of baseline
values. Rocuronium and fentanyl infusion were stopped at the
completion of dural closure. Anesthetic agent under study was
stopped at start of skin closure. After application of dressing, N2O if
in use was discontinued. Time taken for the procedure and total
duration of anesthesia were recorded. Neuromuscular blockade
was reversed with neostigmine (50–70 mg/kg) and glycopyrrolate
(08–10 mg/kg). Tracheal tube was removed only when the patient
started obeying simple commands and his/her vital parameters
were satisfactory. Emergence time (time from turning off N2O to
the time when patient starts obeying simple commands) and
extubation time (time from turning off N2O to removal of tracheal
tube) were noted. Thereafter, all patients were shifted to
neurosurgical intensive care unit for observation and further
management. After discharge from the hospital, patients were
followed up telephonically and in the neurosurgery outpatient
department. At 6–24 months after the discharge, seizure control
was graded using Engel’s criteria.
2.1. Statistical analysis
All the data were analyzed using STATA 9.0 and are presented
as mean (SD) or number (%). Fisher’s exact test and Chi square test
were used for categorical data, whereas, numerical data were
analyzed using two sample ‘t’ test with equal variance. Analysis of
variance (ANOVA) test for 2  2 cross over study was used to
assess the carry over effect (presence of the effect of the ﬁrst
treatment at the time of evaluation of next treatment), treatment
effect (effect of treatment on primary outcome) and period effect
(the tendency of the patient groups to either improve or
deteriorate over time). The value of p less than 0.05 was
considered signiﬁcant.
3. Results
A total of 40 patients were enrolled in the study and were
equally divided into isoﬂurane and propofol groups according to
computerized randomization. One patient in the isoﬂurane group
was excluded because of inability to obtain ECoG recording due to
a technical problem. The individual proﬁles of all the patients in
both the groups are shown in Table 1. The mean (SD) [range] age
(years), body weight (kg), gender distribution (M:F) in the
isoﬂurane and propofol group was 13.9(7.6) [0.75–33] vs
16.9(8.2) [2–28] [p = 0.2], 41(15.9) [7–60] vs 49.6(22.6) [9–85]
[p = 0.2], 12:7 vs 15:5, respectively. In the isoﬂurane group (n = 19),
08 patients had temporal lobe epilepsy and 11 patients had
extratemporal epilepsy whereas in the propofol group (n = 20), the
numbers were 11 and 9 respectively (Table 1). Preoperative and
intraoperative trends of HR, MAP and BIS score were comparable in
both the groups.
Fig. 1. Flowchart showing the study design.
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ECoG could be recorded in all the patients except for one patient
in the isoﬂurane group (due to technical reasons), and was
excluded in the ﬁnal analysis. All patients were operated by single
neurosurgeon (PSC) and the ECoG recordings were evaluated by a
single neurologist (MT) who was blinded to the anesthetic
technique. The recordings were analyzed using scoring system
described by Marthen et al.7 The ECoG grading has been provided
in such a manner so the grade I is normal and grade V is most
abnormal. Thus shifting to a higher grade in the same patient with
a change of anesthetic agent was considered as the agent having a
better capability of detecting optimal ECoG recordings.
3.2. Isoﬂurane group
Mean BIS scores at the time of ECoG recordings were 49(5.7)
and 46(8.8) with air and N2O respectively. The mean inspired
concentration of isoﬂurane during ECoG recordings were 0.8(0.4)
and 0.7(0.2) with air and N2O respectively. Mean ECoG score with
N2O (3.0) was lower than the mean ECoG score with air (3.9)
(p  0.01) (Fig. 2A and B), irrespective of the order of randomiza-
tion of the two gases (Table 2). There was no difference between
the two treatment periods (air/N2O) (p = 0.6). There was no carry
over effect (treatment  period) between the two periods (p = 0.2).
The carryover effect occurs when two treatment conditions are
applied to the same participant, and the effect of the ﬁrst treatment
‘‘carries over’’ to the second.
3.3. Propofol group
The mean BIS scores at the time of ECoG recordings were
50(9.5) and 48(11.3) with air and N2O respectively. The mean ECoG
scores with N2O (3.2) was lower than the mean ECoG with air (3.4)
(Fig. 2C and D), though the difference was not statistically
signiﬁcant (p = 0.5) (Table 2). No difference was observed between
two periods (air or N2O) (p = 0.6). There was no carry over effect
between the two periods (p = 0.2) (Table 2).
The mean ECoG scores in the two groups were analyzed using
two sample ‘t’ test with equal variance. The mean ECoG scores
were comparable in the two groups as shown in Table 3.3.4. The perioperative outcome
In isoﬂurane and propofol group the mean duration of
anesthesia (h), surgery (h), emergence time (min), extubation
time (min), ICU stay and hospital stay (days) were 6.1(1.2) [3–8] vs
6.1(1.3) [4.5–10] [p = 0.94], 4.5(1.3) [2–6] vs 4.9(1.4) [3.5–10]
[p = 0.4], 7.7(9.1) [9–30] vs 5.3(3.9) [2–20] [p = 0.7], 15.9(30.9) [0–
120] vs 7.2(4.8) [3–25] [p = 0.9], 2.7(1.6) [1–7] vs 2.4(1.2) [1–5]
[p = 0.8] and 10.5(5.5) [3–20] vs 9.2(5.3) [4–20] [p = 0.3], respec-
tively. Five patients in isoﬂurane group and one patient in propofol
group required postoperative ventilation.
3.5. Follow up data
Follow up duration was 3–24 months (median = 14 months)
after discharge from the hospital. Twelve out of 19 (63.2%) patients
in isoﬂurane group had good outcome (10, Engel class I and 2, Engel
class II), where as 05 patients experienced worthwhile improve-
ment in seizure control (Engel’s class III). In propofol group, 12
(60.0%) out of 20 patients, had good outcome (7, Engel class I and 5,
Engel class II), 02 patients had worthwhile improvement in seizure
control (Engel’s class III). However, 02 patients in the propofol
group had no worthwhile improvement (Engel’s class IV). Out of
these 02, one patient underwent porencephalic cyst excision,
whereas the other one was operated for mesial temporal sclerosis.
4. Discussion
In our study successful ECoG recordings were possible with use
of BIS titrated doses of either isoﬂurane or propofol. Addition of
nitrous oxide caused suppression of these recordings in both the
groups (p  0.01 vs 0.5). Despite its limitations ECoG is widely used
to demarcate epileptogenic zones. The main shortcomings of ECoG
is the short duration of its recordings, its inability to seldom
capture the seizures and the localization usually relying on inter-
ictal abnormal activity. These inter-ictal discharges may be false
positive or false negative. Lateralization and localization is
required through preoperative work up for correct placement of
ECoG grid.5 The reliability of ECoG is uncertain because relation
between intraoperative and extraoperative spike frequency or the
spatial pattern of spike frequency is not well documented.9 The
Fig. 2. Figures showing ECoG recordings. A and B represent one patient; C and D represent another patient. A shows an ECoG with a score of 3 on isoﬂurane without nitrous
oxide. B in the same patient demonstrate a subsidence of the recordings (score 2) on isoﬂurane with nitrous oxide. C shows an abnormal ECoG activity (score 3) on propofol
without nitrous oxide. The same patient once again shows subsidence of the waveforms (score 2) when subjected to nitrous oxide in addition (D).
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background activity and epileptiform discharges.4 Both anticon-
vulsant as well as proconvulsant properties have been described
with various anesthetic agents and at various doses.10 The primary
objective for choosing an anesthetic agent in a patient scheduled to
undergo ECoG for epilepsy surgery is that it should not provoke
seizure and at the same time should not interfere with recordings.
Isoﬂurane is commonly used anesthetic during ECoG record-
ings.11,12
Fiol et al. have studied the effect of isoﬂurane and nitrous oxide
on ECoG recordings and found that isoﬂurane (0.25–1.25%) along
with N20 (50–70%), has no effect on spike activity.11 Asano et al.,
compared intraoperative and chronic invasive ECoG in 12 children
with neocortical epilepsy.12 At the time of ECoG recording,
anesthesia was maintained with isoﬂurane (0.5–1%, FiO2 0.5).
They observed decrease in the spike frequency under general
anesthesia but it reliably reﬂected the awake inter-ictal spikingTable 2
Mean electrocorticography (ECoG) scores of the patients in both the groups.a
Mean ECoG scoresb Mean ECoG scoresb p-Value
With
nitrous
oxide
With air ~ With air With
nitrous
oxide
~
Isoﬂurane 2.9(1.3) 3.8(1.0) 0.9 4.2(0.8) 3.2(0.8) 1.2 <0.01
Propofol 2.7(1.3) 3.2(1.0) 0.5 3.5(1.2) 3.4(1.1) 0.08 0.5
Treatment effect (p  0.01); period effect (p = 0.6); carry over effect (p = 0.2).
Analysis of variance (ANOVA) test for 2  2 cross over study was used to assess the
carry over effect, treatment effect and period effect.
a Numerical data were analyzed using two sample ‘t’ test with equal variance.
b The two columns represent the sequence of application of two gases (nitrous
oxide followed by air and vice a versa) according to randomization.pattern when spike frequency was >1 spike/min. Higher the
number of spikes, better was the correlation between intra-
operative and postoperative spike frequency pattern. Our ﬁndings
were consistent with previous investigators. We found that
satisfactory ECoG recordings were possible with BIS (50  5)
titrated doses of isoﬂurane (0.5–1.25%) but addition of 50% nitrous
oxide decreased the ECoG scores.
Propofol is a favored agent among the neuroanesthesiolo-
gists, but its use in epilepsy patients and for epilepsy surgery is
debated. Though, the anticonvulsant properties of propofol are
well established, many reports have also highlighted its pro-
convulsant effects.13 Use of propofol has been associated with
generation of beta EEG activity which obscures the underlying
spike wave activity for up to 20 min after stopping its infusion,
which is its major shortcoming for electrocorticographic
monitoring.14,15 However, Samara and colleagues, reported no
signiﬁcant change in epileptiform activity in patients with
complex partial epilepsy receiving sedative doses of propofol.16
Similarly, Schneider and colleagues, studied the effects of
propofol on electrocorticography in patients with intractable
epilepsy and documented no seizure activity or decrease in the
number of spikes or spike burst suppression patterns in ECoG.17Table 3
Comparison of mean ECoG scores in both the anesthetic groups.a
Mean ECoG scores
with nitrous oxide
Mean ECoG
scores with air
Isoﬂurane 3.0(1.2) 3.9(1.0)
Propofol 3.2(1.2) 3.4(1.1)
p-Value 0.7 0.1
a Data was analyzed using two sample ‘t’ test with equal variance.
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activity with a BIS targeted (50  5) dose of propofol. In this
group too the addition of nitrous oxide to the anesthetic regimen
decreased the ECoG scores but it was not statistically signiﬁcant
(p = 0.5).
N2O is considered fairly inert in both development and the
treatment of seizure activity in humans, however, its complex
interactions have been described with other potent anesthetic
agents.10 Artru and Kurita et al. have demonstrated diminution of
spike activity with the use of nitrous oxide in combination with
volatile anesthetics whereas Fiol et al. did not observe any spike
frequency depression with the use of N2O (50–70%) and
recommended its use during ECoG recordings.11,18,19
Fentanyl has been described to possess pro-convulsant
properties and it has been used to evoke seizure during epilepsy
surgery.10,20,21 Tempelhoff and colleagues, studied the effect of
fentanyl (mean dose 25.7 mg/kg) on ECoG and found that the use of
fentanyl in such doses was associated with electrographic
seizures.20 Manninen and colleagues evaluated the effectiveness
of opioids (fentanyl and alfentanil) for intraoperative stimulation
of epileptiform activity in patients undergoing surgery for
intractable temporal lobe epilepsy. They concluded that fentanyl
in a dose of 10 mg/kg can be useful for intraoperative localization of
seizure focus as it induced an increase in spike activity in all
patients.21 We have used low dose fentanyl infusion (1 mg/kg/h) in
both the groups, which is unlikely to result in signiﬁcant
interactions with ECoG recordings.
BIS is widely used as a reliable monitor of anesthetic depth. BIS
has been found to be reliable predictor of level of consciousness
with propofol and isoﬂurane anesthesia.22 However there are
reports of increase in BIS score with the use of nitrous oxide.23
There are opinions both in favor and against the use of BIS
monitoring, but still it remains the most widely used monitor to
titrate the depth of anesthesia.24 Despite extensive literature
search we could not ﬁnd any study evaluating the effect of BIS
targeted anesthetic regimens on ECoG. In this double blind,
randomized cross over study, we found it to be useful monitor for
titration of anesthetic agents for satisfactory ECoG recordings.
Seizure control after epilepsy surgery has been reported to be
variable depending upon the underlying pathology. Tellez-
Zentenol and colleagues in a meta-analysis described long term
seizure control of about 66% with temporal lobe resections, 46%
with occipital and parietal resections, and 27% with frontal lobe
resections.25 Engel have described a seizure control of 67.9% in
patients undergoing limbic resections, 45.1% for neocortical
resections, 67.4% for hemispherectomies, 45.2% for large multi-
lobar resections, 7.6% for corpus callosotomies during 1986–
1990.26 In the present study with 39 patients having temporal and
extratemporal lobe epilepsy, overall long term seizure control
(Engels class I and II) was 62%, with up to 70% seizure control in
patients with temporal lobe epilepsy.
We do acknowledge the limitations of this study (a) use of
single concentration of nitrous oxide, (b) unavailability of baseline
intracranial recordings without anesthesia: an ideal study would
be to compare the ECoG recordings under various anesthetic
agents as well with under awake conditions as would be the case in
invasive recordings. (c) Comparison of partial epilepsies irrespec-
tive of the localization and etiology (temporal lobe epilepsies/
extratemporal lobe epilepsies; neocortical epilepsies/mesial tem-
poral lobe epilepsies; lesional/non-lesional epilepsies). There are
differences in epileptogenecity depending on the localization and
pathology of the epileptogenic zone. However our primaryobjective was to see the effect of various anesthetic agents on
the amplitude and frequency of discharges noting which would
bring out maximum frequency of pick up of discharges and not to
note which etiology produced discharges. In our study each patient
acted as his own control and was not compared with other patients
with different pathology. (d) Small size of cohort. However we
would like to emphasize that this is ﬁrst of its kind of study and
reasonably demonstrates the effect of anesthetic drugs on ECoG
recordings. This study would help in developing protocols, which
would be optimal in performing ECoG.
5. Conclusions
We studied in a double blind, randomized cross over manner,
effects of different anesthetic techniques, on electrocorticography
in patients undergoing epilepsy surgery and found that satisfactory
recordings may be obtained with use BIS titrated doses of either
isoﬂurane or propofol. Addition of nitrous oxide as a carrier gas
reduced the ECoG scores.
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